Bristlecone Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Bristlecone Advisors, LLC

$1.17 Billion
Q3 2025

A detailed history of Bristlecone Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Bristlecone Advisors, LLC holds 15,623 shares of XBI stock, worth $1.69 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

15,623

Previous 16,453 5.04%

Holding current value

$1.69 Million

Previous $1.36 Million 14.74%

% of portfolio

0.13%

Previous 0.12%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	SELL	$83.08 - $100.2 $68,956 - $83,166	-830 Reduced 5.04%	15,623 $1.57 Million
Q2 2025 Aug 04, 2025	SELL	$69.8 - $85.28 $519,800 - $635,080	-7,447 Reduced 31.16%	16,453 $1.36 Million
Q1 2025 May 12, 2025	BUY	$81.1 - $94.7 $393,497 - $459,484	4,852 Added 25.47%	23,900 $1.94 Million
Q4 2024 Jan 29, 2025	SELL	$89.81 - $104.0 $81,278 - $94,120	-905 Reduced 4.54%	19,048 $1.72 Million
Q3 2024 Oct 24, 2024	SELL	$90.87 - $102.43 $19,991 - $22,534	-220 Reduced 1.09%	19,953 $1.97 Million
Q2 2024 Jul 25, 2024	SELL	$82.22 - $94.12 $6,002 - $6,870	-73 Reduced 0.36%	20,173 $1.87 Million
Q1 2024 Apr 22, 2024	BUY	$87.05 - $102.89 $466,239 - $551,078	5,356 Added 35.97%	20,246 $1.92 Million
Q4 2023 Jan 25, 2024	SELL	$64.12 - $90.86 $36,548 - $51,790	-570 Reduced 3.69%	14,890 $1.33 Million
Q3 2023 Oct 16, 2023	SELL	$71.88 - $85.76 $35,940 - $42,880	-500 Reduced 3.13%	15,460 $1.13 Million
Q2 2023 Aug 03, 2023	BUY	$75.38 - $90.23 $690,480 - $826,506	9,160 Added 134.71%	15,960 $1.33 Million
Q1 2023 May 11, 2023	BUY	$73.13 - $91.97 $497,283 - $625,396	6,800 New	6,800 $518,000

Others Institutions Holding XBI

# of Institutions

817

Shares Held

112M

Call Options Held

22.4M

Put Options Held

28.8M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bristlecone Advisors, LLC with notifications on news.

Account

Bristlecone Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History